Skip to main content
Filing year 2024

COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC

Washington, District of Columbia·EIN 68-0299230·501(c)(6)
Total revenue
$1M
Total assets
$2.2M
Total expenses
$951k
Reported officers
23
Mission

CORAR IS THE TRADE ASSOCIATION AND VOICE OF THE RADIONUCLIDES AND RADIOPHARMACEUTICALS INDUSTRY IN NORTH AMERICA. CORAR ADVOCATES FOR PUBLIC POLICIES THAT IMPACT HEALTH CARE, TRANSPORTATION SAFETY, HOMELAND SECURITY, AND MANUFACTURING IN AN EFFORT TO EXPAND ACCESS TO SAFE AND AFFORDABLE HEALTH CARE TREATMENTS FOR ALL.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 1 reported individual · Filing year 2024

Percentile bands compare each position's total pay with the same role at nonprofits nationwide, across all sectors.

Executive Director
75th to 90th percentile
$260k
$276k
Base
$260k
Bonus
Other
Benefits

Teal figures restate each filed amount in 2026 dollars.

Estimated with Washington-Arlington-Alexandria, DC-VA-MD-WV metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 22 unpaid individuals.

Up 3%
from 2023

From $251k in 2023 to $260k in 2024.

$251k
2023
$260k
2024
In today's dollarsEst.
Roughly flat in real terms$275k to $276k

Estimated with Washington-Arlington-Alexandria, DC-VA-MD-WV metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Pay for the position

Chief Executive Officer pay rose 3% from 2023 to 2024, while revenue fell 3%.

$251k in 2023 to $260k in 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.
Financial trend

Revenue and expenses over time

COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC reported revenue and expenses across 2 filing years.

RevenueExpenses
$1.1M
$944k
2023
$1M
$951k
2024
Total revenue and total expenses from IRS Form 990 filings.
FAQ

Common questions about COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC

What does the Chief Executive Officer of COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC earn?

In 2024, the Chief Executive Officer of COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC received $260,040 in total compensation. This pay is in the top quarter for Chief Executive Officer roles among nonprofits nationwide, across all sectors, though not the top 10% of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC compare with similar nonprofits?

Compared with the same role at nonprofits nationwide, across all sectors, the 2024 pay of the Chief Executive Officer at COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC falls between the 75th and 90th percentiles.

What are COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC's revenue and expenses?

In 2024, COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC reported $1M in total revenue and $951k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.